These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12612733)

  • 1. [Treatment of chronic Chagas' disease with an association of nifurtimox and corticoid].
    Rassi A; Amato Neto V; de Siqueira AF; Ferriolli Filho F; Amato VS; Rassi GG; Rassi Junior A
    Rev Soc Bras Med Trop; 2002; 35(6):547-50. PubMed ID: 12612733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCR.
    Solari A; Ortíz S; Soto A; Arancibia C; Campillay R; Contreras M; Salinas P; Rojas A; Schenone H
    J Antimicrob Chemother; 2001 Oct; 48(4):515-9. PubMed ID: 11581230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution.
    Fabbro DL; Streiger ML; Arias ED; Bizai ML; del Barco M; Amicone NA
    Rev Soc Bras Med Trop; 2007; 40(1):1-10. PubMed ID: 17486245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nifurtimox as a prophylactic drug to prevent reactivation in chronic chagasic patients treated with corticoid for associated diseases].
    Rassi A; Neto VA; de Siqueira AF; Leite MS
    Rev Soc Bras Med Trop; 1998; 31(3):249-55. PubMed ID: 9612015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment with a nitrofuranic and a corticoid in experimental Chagas' disease in the dog.
    Andrade SG; Andrade ZA; Sadigursky M
    Am J Trop Med Hyg; 1980 Sep; 29(5):766-73. PubMed ID: 6776831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Longitudinal study and specific chemotherapy in children with chronic Chagas' disease, residing in a low endemicity area of Argentina].
    Streiger ML; del Barco ML; Fabbro DL; Arias ED; Amicone NA
    Rev Soc Bras Med Trop; 2004; 37(5):365-75. PubMed ID: 15361952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of the undetermined form of Chagas disease with nifortimox and benzonidazole].
    Ferreira Hde O
    Rev Soc Bras Med Trop; 1990; 23(4):209-11. PubMed ID: 2133586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of nifurtimox treatment of chronic Chagas disease by means of several parasitological methods.
    Muñoz C; Zulantay I; Apt W; Ortiz S; Schijman AG; Bisio M; Ferrada V; Herrera C; Martínez G; Solari A
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4518-23. PubMed ID: 23836179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of the chronic phase of the experimental infection by Trypanosoma cruzi with benzonidazole and nifurtimox].
    Andrade SG; Magalhães JB; Pontes AL
    Rev Soc Bras Med Trop; 1989; 22(3):113-8. PubMed ID: 2518608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.
    Bianchi F; Cucunubá Z; Guhl F; González NL; Freilij H; Nicholls RS; Ramírez JD; Montilla M; Flórez AC; Rosas F; Saavedra V; Silva N
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003465. PubMed ID: 25723465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiological drug treatment of human infection by Trypanosoma cruzi.
    Levi GC; Lobo IM; Kallás EG; Amato Neto V
    Rev Inst Med Trop Sao Paulo; 1996; 38(1):35-8. PubMed ID: 8762637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO).
    Altcheh J; Castro L; Dib JC; Grossmann U; Huang E; Moscatelli G; Pinto Rocha JJ; Ramírez TE;
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008912. PubMed ID: 33412557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nifurtimox, a bright future for treatment of Chagas disease].
    Wolf A; Boulliat C; Coillot C; Rouault M; Gaillard K; Beranger C; Oliver M
    Med Trop (Mars); 2011 Apr; 71(2):131-3. PubMed ID: 21695868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitrypanosomal therapy for chronic Chagas' disease.
    Bern C
    N Engl J Med; 2011 Jun; 364(26):2527-34. PubMed ID: 21714649
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy of nifurtimox for the treatment of chronic Chagas disease].
    Fuentes B R; Maturana A M; de la Cruz M R
    Rev Chilena Infectol; 2012 Feb; 29(1):82-6. PubMed ID: 22552516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives.
    Braga MS; Lauria-Pires L; Argañaraz ER; Nascimento RJ; Teixeira AR
    Rev Inst Med Trop Sao Paulo; 2000; 42(3):157-61. PubMed ID: 10887376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chagas' disease in patients with renal transplantation].
    Thambo S; Passalacqua W; Van Cauwelaert R; Lazcano F
    Rev Med Chil; 1989 Jan; 117(1):18-22. PubMed ID: 2518278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation].
    Coura JR; de Abreu LL; Willcox HP; Petana W
    Rev Soc Bras Med Trop; 1997; 30(2):139-44. PubMed ID: 9148337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective effect of benznidazole against parasite reactivation in patients chronically infected with Trypanosoma cruzi and treated with corticoids for associated diseases].
    Rassi A; Amato Neto V; de Siqueira AF; Ferriolli Filho F; Amato VS; Rassi Júnior A
    Rev Soc Bras Med Trop; 1999; 32(5):475-82. PubMed ID: 10881079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.